“Abysmal” participation in cancer trials
August 30th, 2011
By Frederik Joelving
NEW YORK | Fri Aug 26, 2011 6:57pm EDT
(Reuters Health) – Very few patients who’ve had cancer surgery end up participating in clinical trials to test new treatments, researchers have found.
And those who do participate are younger and usually white, fueling concerns that new drugs may not fare as well once they hit the market because trial subjects don’t match real-world users.